mRNA expression of complement components and regulators in rat arterial smooth muscle cells

被引:18
作者
Li, WX
Tada, T [1 ]
Miwa, T
Okada, N
Ito, J
Okada, H
Tateyama, H
Eimoto, T
机构
[1] Nagoya City Univ, Sch Med, Dept Pathol, Mizuho Ku, Aichi 4678601, Japan
[2] Nagoya City Univ, Sch Med, Dept Mol Biol, Aichi 4678601, Japan
[3] Nagoya City Univ, Sch Med, Dept Biochem, Aichi 4678601, Japan
关键词
artery; smooth muscle cell; complement; complement regulator; cytokine;
D O I
10.1111/j.1348-0421.1999.tb02445.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The presence of C5b-9 complexes, some complement regulators, and abundant cytokines in atherosclerotic lesions has been reported. However, it is unclear whether these complement-associated proteins are produced by vascular smooth muscle cells (SMCs) and how they are influenced by the cytokines, In the present study, we demonstrated, by the reverse transcription-polymerase chain reaction method, the mRNA expression of complement components (C3, C4, and C5) and membrane regulators (decay-accelerating factor, membrane cofactor protein, Crry, and CD59) in cultured SMCs derived from the rat carotid artery. The expression of C9 mRNA was also induced upon stimulation by interferon-gamma (IFN-gamma), tumor necrosis factor-alpha (TNF-alpha) and/or lipopolysaccharide (LPS), Northern blot analysis showed that the mRNA expression of C3, C4, DAF and Crry was up-regulated, but that of CD59 was down-regulated by IFN-gamma, TNF-alpha and/or LPS alone or by synergy The increase of C3 mRNA by TNF-or or LPS and that of C4 mRNA by IFN-gamma was induced in a dose-dependent manner. The results indicate that the arterial SMCs of rat have the ability to produce complement components and regulators, which is affected by cytokines and/or LPS, Since atherosclerosis is characterized by the intimal proliferation of SMCs, the complement system including its regulators may be involved in the pathogenesis of the disease.
引用
收藏
页码:585 / 593
页数:9
相关论文
共 65 条
[61]   Production of the third and fourth component of complement (C3, C4) by smooth muscle cells [J].
Ueda, Y ;
Nagasawa, K ;
Tsukamoto, H ;
Horiuchi, T ;
Nishizaka, H ;
Ikeda, K ;
Niho, Y .
IMMUNOLOGY, 1996, 89 (02) :183-188
[62]   STRUCTURAL FEATURES OF THE HUMAN C3-GENE - INTRON EXON ORGANIZATION, TRANSCRIPTIONAL START SITE, AND PROMOTER REGION SEQUENCE [J].
VIK, DP ;
AMIGUET, P ;
MOFFAT, GJ ;
FEY, M ;
AMIGUETBARRAS, F ;
WETSEL, RA ;
TACK, BF .
BIOCHEMISTRY, 1991, 30 (04) :1080-1085
[63]   IMMUNOHISTOCHEMICAL LOCALIZATION OF THE TERMINAL C5B-9 COMPLEMENT COMPLEX IN HUMAN AORTIC FIBROUS PLAQUE [J].
VLAICU, R ;
NICULESCU, F ;
RUS, HG ;
CRISTEA, A .
ATHEROSCLEROSIS, 1985, 57 (2-3) :163-177
[64]  
WARNER SJC, 1989, J IMMUNOL, V142, P100
[65]  
WHITE RT, 1992, J BIOL CHEM, V267, P9210